We are pleased to announce that Carola Neumann, MD, has agreed to serve as the Program Co-Director of the Oncology Graduate Program, effective September 1, 2025.
Dr. Neumann is an associate professor of Pharmacology and Chemical Biology and serves as the Vice Chair for Precision and Translational Pharmacology. Her work seeks to expand knowledge of cell signaling that is in part mediated by oxidation and reducing (redox) reactions as reactive oxygen species (ROS) deregulate the redox homeostasis and promote tumor formation by initiating an aberrant induction of signaling networks that cause tumorigenesis, including breast cancer. To investigate the specific mechanisms underlying redox-induced tumorigenesis, the Neumann laboratory focuses on the redox-induced posttranslational modifications (PTM) of protein cysteines, which are essential in cell signaling. Peroxiredoxin 1 (PRDX1) is a peroxidase that has emerged as a critical protein in cell signaling as it scavenges the second messenger H2O2, binds to and regulates signaling proteins, and when knocked out in mice, causes a variety of cancers, including breast cancer.
Dr. Neumann has an exceptional history of mentorship, and we are greatly looking forward to all that she brings to the Oncology Graduate Program and its students.
